Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 5 (2008), Issue 11 (November)

1. Errors with concentrated epinephrine in otolaryngology.
   Laryngoscope, 118(11): 1928-30. [Abstract] [Full-text]
2. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial.
   Pediatrics, 122(5): 1064-71. [Abstract] [Full-text]
3. Trends in the prevalence of chronic medication use in children: 2002-2005.
   Pediatrics, 122(5): e1053-61. [Abstract] [Full-text]
4. Occult cervical (C1-2) dural tear causing bilateral recurrent subdural hematomas and repaired with cervical epidural blood patch.
   J Neurosurg Spine, 9(5): 483-7. [Abstract] [Full-text]
5. Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.
   J Neurosurg, 109(5): 874-80. [Abstract] [Full-text]
6. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
   J Neurosurg, 109(5): 867-73. [Abstract] [Full-text]
7. MRI in ocular drug delivery.
   NMR Biomed, 21(9): 941-56. [Abstract] [Full-text]
8. Association between different restraint use and rear-seated child passenger fatalities: a matched cohort study.
   Arch Pediatr Adolesc Med, 162(11): 1085-9. [Abstract] [Full-text]
9. The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.
   J Acquir Immune Defic Syndr, 49(3): 266-71. [Abstract] [Full-text]
10. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr, 49(3): 276-81. [Abstract] [Full-text]
11. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Am J Obstet Gynecol, 199(5): e6-8. [Abstract] [Full-text]
12. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles.
    Biochem Biophys Res Commun, 377(1): 35-40. [Abstract] [Full-text]
13. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Am J Ophthalmol, 146(5): 700-6. [Abstract] [Full-text]
14. Use of customized MIC-KEY gastrostomy button for management of MACE stomal complications.
    Urology, 72(5): 1026-9. [Abstract] [Full-text]
15. Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers.
    Am J Obstet Gynecol, 199(5): 526.e1-7. [Abstract] [Full-text]
16. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
    Clin Infect Dis, 47(11): 1479-85. [Abstract] [Full-text]
17. Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.
    J Clin Oncol, 26(32): 5192-7. [Abstract] [Full-text]
18. High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.
    J Clin Oncol, 26(32): 5175-82. [Abstract] [Full-text]
19. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
    J Clin Oncol, 26(32): 5156-64. [Abstract] [Full-text]
20. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
    J Clin Oncol, 26(32): 5254-60. [Abstract] [Full-text]
21. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
    J Clin Oncol, 26(32): 5240-7. [Abstract] [Full-text]
22. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
    J Clin Oncol, 26(32): 5233-9. [Abstract] [Full-text]
23. Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.
    J Clin Oncol, 26(32): 5261-8. [Abstract] [Full-text]
24. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
    Blood, 112(10): 3982-8. [Abstract] [Full-text]
25. Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
    Blood, 112(10): 3989-94. [Abstract] [Full-text]
26. Nursing peer review: developing a framework for patient safety.
    J Nurs Adm, 38(11): 475-9. [Abstract] [Full-text]
27. Prescribing by pharmacists in Alberta.
    Am J Health Syst Pharm, 65(22): 2126-32. [Abstract] [Full-text]
28. A novel approach of prophylaxis to HBV recurrence after liver transplantation.
    Virology, 382(1): 1-9. [Abstract] [Full-text]
29. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
    Fertil Steril, 90(5): 1969-72. [Abstract] [Full-text]
30. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
    Fertil Steril, 90(5): 1635-9. [Abstract] [Full-text]
31. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.
    Fertil Steril, 90(5): 1805-11. [Abstract] [Full-text]
32. Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense.
    Biotechnol Bioeng, 101(6): 1313-20. [Abstract] [Full-text]
33. Self-assembled prodrugs: an enzymatically triggered drug-delivery platform.
    Biomaterials, 30(3): 383-93. [Abstract] [Full-text]
34. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs.
    Biomaterials, 30(3): 374-82. [Abstract] [Full-text]
35. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
    Arch Intern Med, 168(20): 2245-53. [Abstract] [Full-text]
36. Thrombolytic therapy and mortality in patients with acute pulmonary embolism.
    Arch Intern Med, 168(20): 2183-90; discussion 2191-2. [Abstract] [Full-text]
37. CroFab reconstitution in various media: an in vitro solubility study.
    Clin Toxicol (Phila), 46(9): 808-10. [Abstract] [Full-text]
38. Acute tacrolimus toxicity in a non-transplant patient.
    Clin Toxicol (Phila), 46(9): 838-40. [Abstract] [Full-text]
39. The antithrombotic effects of carrot filtrates in rats and mice.
    Blood Coagul Fibrinolysis, 19(8): 785-92. [Abstract] [Full-text]
40. Accuracy of intra-articular injections in peripheral joints performed blindly in patients with rheumatoid arthritis.
    Rheumatology (Oxford), 47(12): 1792-4. [Abstract] [Full-text]
41. Multifunctional magnetic nanocarriers for image-tagged SiRNA delivery to intact pancreatic islets.
    Transplantation, 86(9): 1170-7. [Abstract] [Full-text]
42. Comparison of multiple session 99% ethanol and single session OK-432 sclerotherapy for the treatment of simple renal cysts.
    J Urol, 180(6): 2552-6. [Abstract] [Full-text]
43. Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer.
    J Urol, 180(6): 2389-95. [Abstract] [Full-text]
44. Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder.
    J Urol, 180(6): 2384-8; discussion 2388. [Abstract] [Full-text]
45. Uncalibrated pulse contour-derived stroke volume variation predicts fluid responsiveness in mechanically ventilated patients undergoing liver transplantation.
    Br J Anaesth, 101(6): 761-8. [Abstract] [Full-text]
46. Estrogen and progestogen therapy in postmenopausal women.
    Fertil Steril, 90(5): S88-102. [Abstract] [Full-text]
47. Barley transformation using biolistic techniques.
    Methods Mol Biol, 478: 125-36. [Abstract] [Full-text]
48. Biolistics transformation of wheat.
    Methods Mol Biol, 478: 71-92. [Abstract] [Full-text]
49. Chemiluminescence change of polyphenol dendrimers with different core molecules.
    Org Lett, 10(22): 5171-4. [Abstract] [Full-text]
50. Quantifying diffusion in mucosal systems by pulsed-gradient spin-echo NMR.
    Adv Drug Deliv Rev, 60(15): 1570-82. [Abstract] [Full-text]
51. Nanoparticles in photodynamic therapy: an emerging paradigm.
    Adv Drug Deliv Rev, 60(15): 1627-37. [Abstract] [Full-text]
52. Polysaccharides-based nanoparticles as drug delivery systems.
    Adv Drug Deliv Rev, 60(15): 1650-62. [Abstract] [Full-text]
53. Inner ear drug delivery for auditory applications.
    Adv Drug Deliv Rev, 60(15): 1583-99. [Abstract] [Full-text]
54. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Adv Drug Deliv Rev, 60(15): 1663-73. [Abstract] [Full-text]
55. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Adv Drug Deliv Rev, 60(15): 1615-26. [Abstract] [Full-text]
56. Hydrogel nanoparticles in drug delivery.
    Adv Drug Deliv Rev, 60(15): 1638-49. [Abstract] [Full-text]
57. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    J Clin Oncol, 26(33): 5416-21. [Abstract] [Full-text]
58. Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
    J Clin Oncol, 26(33): 5407-15. [Abstract] [Full-text]
59. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
    J Clin Oncol, 26(33): 5344-51. [Abstract] [Full-text]
60. Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study.
    J Clin Oncol, 26(33): 5335-43. [Abstract] [Full-text]
61. Restoration of patency in iliofemoral deep vein thrombosis with catheter-directed thrombolysis does not always prevent post-thrombotic damage.
    Eur J Vasc Endovasc Surg, 36(6): 725-30. [Abstract] [Full-text]
62. A prospective study of patient adherence to topical treatments: 95% of patients underdose.
    J Am Acad Dermatol, 59(6): 975-80. [Abstract] [Full-text]
63. Formulations for delivery of therapeutic proteins.
    Biotechnol Lett, 31(1): 1-11. [Abstract] [Full-text]
64. Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer.
    Cancer Lett, 272(2): 307-15. [Abstract] [Full-text]
65. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
    Am J Respir Crit Care Med, 178(11): 1139-47. [Abstract] [Full-text]
66. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Eur J Haematol, 81(6): 448-53. [Abstract] [Full-text]
67. Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE.
    Eur J Haematol, 81(6): 432-6. [Abstract] [Full-text]
68. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Pediatr Blood Cancer, 52(1): 14-9. [Abstract] [Full-text]
69. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    Ann Emerg Med, 52(6): 665-76. [Abstract] [Full-text]
70. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Am J Cardiol, 102(11): 1427-32. [Abstract] [Full-text]
71. When to start antiretroviral therapy?
    Clin Infect Dis, 47(12): 1580-6. [Abstract] [Full-text]
72. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Clin Infect Dis, 47(12): 1507-12. [Abstract] [Full-text]
73. Gamma knife radiosurgery for skull base meningiomas: long-term radiologic and clinical outcome.
    Int J Radiat Oncol Biol Phys, 72(5): 1324-32. [Abstract] [Full-text]
74. Exploring the role of novel agents in the treatment of renal cell carcinoma.
    Cancer Treat Rev, 34(8): 750-60. [Abstract] [Full-text]
75. Case report: protothecal tenosynovitis.
    Clin Orthop Relat Res, 466(12): 3143-6. [Abstract] [Full-text]
76. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
    Am J Ophthalmol, 146(6): 935-41.e1. [Abstract] [Full-text]
77. The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.
    Cancer Treat Rev, 34(8): 710-8. [Abstract] [Full-text]
78. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Cancer Treat Rev, 34(8): 693-700. [Abstract] [Full-text]
79. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Int J Radiat Oncol Biol Phys, 72(5): 1378-84. [Abstract] [Full-text]
80. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
    Int J Radiat Oncol Biol Phys, 72(5): 1465-71. [Abstract] [Full-text]
81. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
    Int J Radiat Oncol Biol Phys, 72(5): 1319-23. [Abstract] [Full-text]
82. Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells.
    Cancer Lett, 273(1): 164-71. [Abstract] [Full-text]
83. Potentiation of naphthoxyloside cytotoxicity on human tumor cells by difluoromethylornithine and spermine-NONOate.
    Cancer Lett, 273(1): 148-54. [Abstract] [Full-text]
84. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.
    Am Heart J, 156(6): 1035-44. [Abstract] [Full-text]
85. 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
    Br J Cancer, 99(11): 1842-8. [Abstract] [Full-text]
86. Patient-specific dose finding based on bivariate outcomes and covariates.
    Biometrics, 64(4): 1126-36. [Abstract] [Full-text]
87. A statistical framework for quantile equivalence clinical trials with application to pharmacokinetic studies that bridge from HIV-infected adults to children.
    Biometrics, 64(4): 1117-25. [Abstract] [Full-text]
88. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    J Med Virol, 81(1): 1-8. [Abstract] [Full-text]
89. Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells.
    J Med Virol, 81(1): 9-15. [Abstract] [Full-text]
90. Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer.
    BJU Int, 102(11): 1607-9. [Abstract] [Full-text]
91. Polymeric micellar delivery systems in oncology.
    Jpn J Clin Oncol, 38(12): 793-802. [Abstract] [Full-text]
92. Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.
    Jpn J Clin Oncol, 38(12): 810-5. [Abstract] [Full-text]
93. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Jpn J Clin Oncol, 38(12): 803-9. [Abstract] [Full-text]
94. A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer.
    BJU Int, 102(11): 1601-6. [Abstract] [Full-text]
95. Slow-releasing paclitaxel in polytetrafluoroethylene/polylactide-co-glycolide laminate delays adjustment after strabismus surgery in rabbit model.
    Invest Ophthalmol Vis Sci, 49(12): 5340-5. [Abstract] [Full-text]
96. TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
    Int J Cancer, 124(3): 644-52. [Abstract] [Full-text]
97. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment.
    Int J Cancer, 124(3): 722-8. [Abstract] [Full-text]
98. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
    Int J Cancer, 124(3): 630-7. [Abstract] [Full-text]
99. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
    Lancet Oncol, 9(12): 1135-42. [Abstract] [Full-text]
100. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
     J Pain, 9(12): 1144-54. [Abstract] [Full-text]

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.